Laparoscopic Colorectal surgery
Conditions
Interventions
Group A:3mg/ml ropivacaine(30ml)+epinephrine(0.5mg)+dexamethasone(10mg)+Intravenous analgesia pump N0.1
Group B:3mg/ml ropivacaine(30ml)+epinephrine(0.5mg)+Intravenous analgesia pump N0.1
Group C:Intravenous analgesia pump N0.2+Incision normal saline injections
Group D:Intravenous analgesia pump N0.2+3mg/ml ropivacaine(30ml)+epinephrine(0.5mg)
Group E:Intravenous analgesia pump N0.2+3mg/ml ropivacaine(30ml)+epinephrine(0.5mg)+dexamethasone(10mg)
Sponsors
The First Affiliated Hospital of Shantou University Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Eligible subjects aged 18 years or older, ASA I to II, scheduled for Laparoscopic colorectal resection, BMI 15kg/m2 to 28kg/m2, chronic pain, and without neoadjuvant chemoradiotherapy Before the operation.
Exclusion criteria
Exclusion criteria: Exclusion of ropivacaine or dexamethasone local anesthetic allergies, Severe central neurologic diseases, patients with liver and renal insufficiency, history of alcohol and opioid dependence, Except for emergency surgery, hematological system diseases and Inflammatory bowel disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory biomarkers;Incision healing;The bowel function recovery time;Opioid consumption; | — |
Countries
China
Contacts
Public ContactWei Li
The First Affiliated Hospital of Shantou University Medical College
Outcome results
None listed